Source:http://linkedlifedata.com/resource/pubmed/id/15585981
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-12-8
|
pubmed:abstractText |
The innate immune system encompasses natural killer (NK) cells, macrophages and granulocytes, the complement system and antimicrobial peptides. Recognition pathways of the innate immune system include microbial non-self recognition, missing-self recognition and induced- self recognition. The central nervous system (CNS) participates in responses of the innate immune system. However, immune inhibitory and anti-inflammatory mechanisms physiologically outbalance and counteract immune activity and thereby limit immune-mediated tissue damage in the brain. Human gliomas appear to take advantage of this immunosuppressive milieu. Moreover, glioma cells themselves interfere with anti-tumor immune responses by expressing immune inhibitory cell surface molecules, such as HLA-G, or by releasing soluble immunosuppressants such as transforming growth factor (TGF)-beta. Yet, although glioma cells exhibit all cellular features of malignancy, these tumors very rarely metastasize outside the brain, raising the possibility of immune-mediated control of these cells outside, but not inside, the brain. Accordingly, activating the innate immune system by forcing glioma cells to express danger signals such as NKG2D ligands is a promising strategy of immunotherapy for these tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0378-584X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 S. Karger GmbH, Freiburg.
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-91
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15585981-Animals,
pubmed-meshheading:15585981-Brain Neoplasms,
pubmed-meshheading:15585981-Central Nervous System Neoplasms,
pubmed-meshheading:15585981-Complement System Proteins,
pubmed-meshheading:15585981-Glioma,
pubmed-meshheading:15585981-Humans,
pubmed-meshheading:15585981-Immunity, Innate,
pubmed-meshheading:15585981-Immunotherapy,
pubmed-meshheading:15585981-Killer Cells, Natural,
pubmed-meshheading:15585981-Major Histocompatibility Complex
|
pubmed:year |
2004
|
pubmed:articleTitle |
The innate immune response in the central nervous system and its role in glioma immune surveillance.
|
pubmed:affiliation |
Abteilung für Allgemeine Neurologie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neurologie, Universität Tübingen, Tübingen, Germany.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|